XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
MARKETABLE SECURITIES
9 Months Ended
Sep. 30, 2022
Marketable Securities Abstract  
MARKETABLE SECURITIES

5. MARKETABLE SECURITIES:

Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at September 30, 2022, were as follows:

Amortized

Gross Unrealized

Estimated Fair

(In thousands)

    

Cost

    

Gains

    

Losses

    

Market Value

Investments due in 3 months or less:

 

  

 

  

 

  

 

  

Corporate securities

$

8,412

$

$

(36)

$

8,376

Total

 

8,412

 

 

(36)

 

8,376

Investments due in 4-12 months:

 

  

 

  

 

  

 

  

Corporate securities

 

159,313

 

 

(4,369)

 

154,944

Total

 

159,313

 

 

(4,369)

 

154,944

Investments due in 12 months or greater:

 

  

 

  

 

  

 

  

Corporate securities

 

69,266

 

 

(2,832)

 

66,434

Total

69,266

 

(2,832)

 

66,434

Total marketable securities

$

236,991

$

$

(7,237)

$

229,754

Accrued interest receivable was $1.3 million at September 30, 2022 and was recorded within prepaid expenses and other current assets on the condensed consolidated balance sheet.

Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at December 31, 2021, were as follows:

Amortized

Gross Unrealized

Estimated Fair

(In thousands)

    

Cost

    

Gains

    

Losses

    

Market Value

Investments due in 3 months or less:

 

  

 

  

 

  

 

  

Commercial paper

$

89,965

$

$

$

89,965

Corporate securities

7,285

(3)

7,282

Total

 

97,250

 

 

(3)

 

97,247

Investments due in 4-12 months:

 

  

 

  

 

  

 

  

Corporate securities

 

25,054

 

 

(42)

 

25,012

Total

 

25,054

 

 

(42)

 

25,012

Investments due in 12 months or greater:

 

  

 

  

 

  

 

  

Corporate securities

251,096

 

21

 

(1,141)

 

249,976

Total

 

251,096

 

21

 

(1,141)

 

249,976

Total marketable securities

$

373,400

$

21

$

(1,186)

$

372,235

Accrued interest receivable was $1.5 million at December 31, 2021 and was recorded within prepaid expenses and other current assets on the condensed consolidated balance sheet.

The following table summarizes marketable securities classified as available-for-sale (excluding cash equivalents) in a continuous unrealized loss position for which an allowance for credit losses was not recorded at September 30, 2022:

Less Than 12 Months

12 Months or Longer

Total

    

Estimated

    

Gross

    

Estimated

    

Gross

    

Estimated

    

Gross

Fair Market

Unrealized

Fair Market

Unrealized

Fair Market

Unrealized

(In thousands)

Value

Losses

Value

Losses

Value

Losses

Corporate securities

$

178,374

$

(5,520)

$

51,379

$

(1,717)

$

229,753

$

(7,237)

Total marketable securities

$

178,374

$

(5,520)

$

51,379

$

(1,717)

$

229,753

$

(7,237)

In the three and nine months ended September 30, 2022 and 2021, no unrealized losses on marketable securities were recognized in income.

The Company does not intend to sell and it is unlikely that it will be required to sell the securities prior to their anticipated recovery. The issuers are high quality (investment grade) and the decline in fair value is largely due to changes in interest rates. Additionally, the issuers continue to make timely interest payments on the marketable securities with the fair value expected to recover as they reach maturity.